Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression

Blood

Volumn 123, Issue 13, 2014, Pages 2116-2126

  Vassallo, Paula Frizera ^a,f   Simoncini, Stéphanie ^a   Ligi, Isabelle ^a,b   Chateau, Anne Line ^a   Bachelier, Richard ^a   Robert, Stéphane ^a   Morere, Julia ^c   Fernandez, Samantha ^d   Guillet, Benjamin ^a,d   Marcelli, Maxime ^b   Tellier, Edwige ^a   Pascal, Alain ^e   Simeoni, Umberto ^a,b   Anfosso, Francine ^a   Magdinier, Frédérique ^c   Dignat George, Françoise ^a,b   Sabatier, Florence ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c CNRS   (France)

^d Aix Marseille University   (France)

^e HÔPITAL SAINT JOSEPH   (France)

^f FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ADENINE DINUCLEOTIDE; ADENINE NUCLEOTIDE; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEACETYLASE; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIAL COLONY FORMING CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPIGENETICS; GENE OVEREXPRESSION; GENE SILENCING; GESTATIONAL AGE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TELOMERE SHORTENING; TERM BIRTH; UMBILICAL CORD BLOOD;

CASE-CONTROL STUDIES; CELL AGING; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREMATURE BIRTH; SIRTUIN 1; STRESS, PHYSIOLOGICAL;

EID: 84897516843     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-484956     Document Type: Article

References (55)

1. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2(8663):577-580. (Pubitemid 19216205)
2. Ligi I, Grandvuillemin I, Andres V, Dignat-George F, Simeoni U. Low birth weight infants and the developmental programming of hypertension: a focus on vascular factors. Semin Perinatol. 2010;34(3):188-192.
3. Lazdam M, de la Horra A, Pitcher A, et al. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension. 2010;56(1):159-165.
4. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 2004;287(3):C572-C579. (Pubitemid 39095841)
5. Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv. 2007;70(4):477-484. (Pubitemid 47597014)
6. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593-600. (Pubitemid 36204953)
7. Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111(22):2981-2987. (Pubitemid 40814192)
8. Werner N, Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med. 2007;39(2):82-90. (Pubitemid 46598174)
9. Hwang HS, Maeng YS, Park YW, Koos BJ, Kwon YG, Kim YH. Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction. Am J Obstet Gynecol. 2008;199(3):259.e1-259.e7.
10. Ingram DA, Lien IZ, Mead LE, et al. In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function. Diabetes. 2008;57(3):724-731.
11. Kwon J-Y, Maeng Y-S, Kwon Y-G, Kim YH, Kang MH, Park YW. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol Obstet Invest. 2007;64(2):103-108. (Pubitemid 47294469)
12. Borghesi A, Massa M, Campanelli R, et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2009;180(6):540-546.
13. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097-1108.
14. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105(13):1541-1544. (Pubitemid 34297628)
15. Chen J, Brodsky SV, Goligorsky DM, et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res. 2002;90(12):1290-1298. (Pubitemid 34787411)
16. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol. 2004;31(7):407-413. (Pubitemid 39044118)
17. Ligi I, Simoncini S, Tellier E, et al. A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants. Blood. 2011;118(6):1699-1709.
18. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001;15(2):447-457. (Pubitemid 32141436)
19. Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett. 2009;286(1):103-113.
20. Goligorsky MS, Chen J, Patschan S. Stress-induced premature senescence of endothelial cells: a perilous state between recovery and point of no return. Curr Opin Hematol. 2009;16(3):215-219.
21. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005;37(5):961-976. (Pubitemid 40311739)
22. Stein GH, Drullinger LF, Soulard A, Dulić V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19(3):2109-2117. (Pubitemid 29098269)
23. Lim S, Metzger E, Schüle R, Kirfel J, Buettner R. Epigenetic regulation of cancer growth by histone demethylases. Int J Cancer. 2010;127(9):1991-1998.
24. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem. 2002;277(47):45099-45107. (Pubitemid 36159111)
25. Avalos JL, Bever KM, Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell. 2005;17(6):855-868. (Pubitemid 40386946)
26. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007;100(1):15-26. (Pubitemid 46074968)
27. Takahashi T, Kalka C, Masuda H, et al. Ischemiaand cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5(4):434-438. (Pubitemid 29180584)
28. Coleman PR, Hahn CN, Grimshaw M, et al. Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood. 2010;116(19):4016-4024.
29. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45(9):1441-1448. (Pubitemid 40615616)
30. Donmez G, Guarente L. Aging and disease: connections to sirtuins. Aging Cell. 2010;9(2):285-290.
31. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004;73:417-435. (Pubitemid 39050375)
32. Cheng H-L, Mostoslavsky R, Saito S, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA. 2003;100(19):10794-10799. (Pubitemid 37140107)
33. Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124(2):315-329. (Pubitemid 43121980)
34. Li Y, Tollefsbol TO. p16(INK4a) suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms. PLoS ONE. 2011;6(2):e17421.
35. Kwon H-S, Ott M. The ups and downs of SIRT1. Trends Biochem Sci. 2008;33(11):517-525.
36. Potente M, Ghaeni L, Baldessari D, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21(20):2644-2658. (Pubitemid 47607673)
37. Chen Z, Shentu TP, Wen L, Johnson DA, Shyy JY. Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium. Antioxid Redox Signal. 2013;19(13):1522-1538.
38. Salminen A, Kaarniranta K, Kauppinen A. Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int J Mol Sci. 2013;14(2):3834-3859.
39. Jankov RP, Negus A, Tanswell AK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res. 2001;50(6):681-687. (Pubitemid 33121635)
40. Paschalaki KE, Starke RD, Hu Y, et al. Dysfunction of endothelial progenitor cells from smokers and COPD patients due to increased DNA damage and senescence [published online ahead of print July 29, 2013]. Stem Cells.
41. Potente M, Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle. 2008;7(14):2117-2122. (Pubitemid 352036236)
42. Mattagajasingh I, Kim C-S, Naqvi A, et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2007;104(37):14855-14860. (Pubitemid 350003232)
43. Takemura A, Iijima K, Ota H, et al. Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2054-2062.
44. Tauzin L, Rossi P, Giusano B, et al. Characteristics of arterial stiffness in very low birth weight premature infants. Pediatr Res. 2006;60(5):592-596. (Pubitemid 44627408)
45. Wu Z, Liu M-C, Liang M, Fu J. Sirt1 protects against thrombomodulin down-regulation and lung coagulation after particulate matter exposure. Blood. 2012;119(10):2422-2429.
46. de Kreutzenberg SV, Ceolotto G, Papparella I, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes. 2010;59(4):1006-1015.
47. Guarente L. Franklin H. Epstein Lecture: sirtuins, aging, and medicine. N Engl J Med. 2011;364(23):2235-2244.
48. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107(1):139-146. (Pubitemid 36070946)
49. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88(4 Pt 1):1456-1462. (Pubitemid 23296891)
50. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol. 2007;292(1):H1-H18. (Pubitemid 46105160)
51. Ben-Shoshan J, George J. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials. Pharmacol Ther. 2007;115(1):25-36. (Pubitemid 46990551)
52. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450(7170):712-716. (Pubitemid 350207685)
53. Camins A, Sureda FX, Junyent F, et al. Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta. 2010;1799(10-12):740-749.
54. Hsieh T-C, Lu X, Guo J, Wu JM. Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol. Int J Mol Med. 2010;26(5):743-749.
55. Wang X-B, Zhu L, Huang J, et al. Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin Med J (Engl). 2011;124(24):4310-4315.